The overall survival rates of breast cancer patients based on the expression of these three genes (SMS, PAFAH1B2 and PDK3) were analyzed by UCSC Xena (data retrieved on November 24, 2020) [19]. This evidence concerns the gene PAFAH1B2 and breast cancer.